Zoie Aiken

Dr Aiken has over 20 years of experience working in clinical microbiology and is based at Manchester Foundation Trust. Her specialist areas are in the management of infections in paediatric haematology and stem-cell transplant patients and critical care patients. She has a keen interest in education and oversees the training of Clinical Scientists locally as an STP Training Officer and nationally as Training and Education Lead for the LabMed Microbiology Professional Committee and Lead Assessor for the NSHCS end point assessments. She is also joint Head of Research and Development for the Manchester Medical Microbiology Partnership (MMMP) and Deputy Chair of the Paediatric Antimicrobial Guideline Development Group.

Pronouns:  She/her/hers

Wiebke Arlt

Wiebke Arlt is the Director of the MRC Laboratory of Medical Sciences (LMS), one of two intramural research institute of the UK Medical Research Council. The LMS is located on the Imperial Hammersmith Campus in London and is dedicated to the investigation of mechanisms underlying cardiometabolic disease and ageing, with a special focus on sex differences.

At the LMS, Wiebke leads a multi-disciplinary research group that investigates steroid metabolism and action in health and disease, with a focus on the sex-specific role of androgens in metabolic dysfunction. Wiebke is also an honorary consultant endocrinologist at Imperial College Healthcare NHS Trust with a special interest in adrenal and reproductive disorders.

Wiebke's scientific work has attracted major national and international prizes. She was elected Fellow of the UK Academy of Medical Sciences in 2010.

Nick Armfield

Nick Armfield MSc MIBMS is a senior biomedical scientist at The Walton Centre for Neurology and Neurosurgery. Nick gained a BSc (Hons) at Liverpool John Moores University and qualified at Salford Royal biochemistry. Following a specialist role at Liverpool Clinical Laboratories, a MSc at University of Chester and over a decade’s experience in NHS laboratories, Nick is now a specialist in neuroimmunology and neurobiochemistry. The Walton Centre Neuroimmunology lab offers incite into neuroinflammation by offering the classical tests oligoclonal bands by isoelectric focussing and CSF index. With the emergence of CSF κ Free Light Chain as a marker of intrathecal inflammation, Nick’s recent work has explored the benefits of alternative laboratory markers of intrathecal inflammation. Other professional activities include published and presented works for therapeutic monitoring of ketamine and metabolites.

Prounouns:  He/him/his

Rue Ball

Rue graduated as a Clinical Scientist in 2021. She has worked in routine biochemistry at Synnovis for three years, and during that time she has done audits, research and teaching to improve the care medical laboratories provide to trans & non-binary people. She is co-chief investigator of a forthcoming nationwide study about PSA reference intervals in trans women and non-binary people with a prostate.

Pronouns:  She/they

Ann Bowron

No bio provided

Charlotte Brookfield

I work across all the acute adult hospitals in Liverpool with a particular specialist interest in mycobacterial and vascular infections. I am laboratory lead for the microbiology department at Liverpool Clinical Laboratories and have a passion for diagnostic stewardship.

Pronouns: She/Her

Greg Bulmer

I am currently a 3^rd year Trainee Clinical Scientist in Biochemistry at University Hospitals Birmingham NHS Foundation Trust. A research background in carbohydrate and organic volatile chemistry led me to an interest in various hyphenated mass spectrometry techniques.   My current interests include the clinical application of LC-MS/MS in the development of non-invasive tests for at-home or paediatric populations, such as salivary steroid quantification.

Pronouns: He/him

Carrie Chadwick

Carrie completed her Clinical Scientist Training at South Manchester University Hospital Trust and Royal Liverpool University Hospital.   She was appointed as a Principal Clinical Scientist at Aintree University Hospital and also at The Walton Centre NHS Foundation Trust in 2008, where she specialised in Neurobiochemistry and Neuroimmunology. Carrie was appointed as Consultant Clinical Scientist and Clinical Director at The Neuroscience Laboratories at The Walton Centre NHS Foundation Trust in 2013.

Carrie has a specialist interest in paraneoplastic antibodies, neurodegeneration, neuroinflammation, therapeutic drug monitoring and biobanking; she established a cerebrospinal fluid and blood bio bank at the Trust in 2016, which has since been renamed The Liverpool Neuroscience Biobank at The Walton Centre (LNBW). The LNBW has enabled collaborative translational research with local health partners.  Carrie is also the current LabMed Chair for the North-West region.

Pronouns:  She/her

Kamaljit Chatha

Dr Kamaljit Chatha is a Consultant Clinical Biochemist, Clinical Lead for Biochemistry and Immunology and Director of the Bowel Cancer Screening Midlands and North West Hub at the University Hospitals Coventry and Warwickshire (UHCW).  Kamaljit has a keen interest in research and development and has several publications that covers the novel and innovative use of biomarkers to detect chronic disease such as cardiovascular disease and renal disease.  She also has an interest in screening, as highlighted by her work in Bowel Cancer Screening, and combine FIT with artificial intelligence systems to improve bowel cancer detection in the screening programme.  Kamaljit has been actively involved with regional and national Association for Laboratory Medicine (ALM) committees and is currently Director of Publications and Communications for the ALM, promoting the profession and the excellent work it delivers.  Kamaljit is also an Honorary Clinical Lecturer for the University of Warwick and is part of the Institute of Cardiometabolic Medicine (ICMM) at UHCW.

Prounouns:  She/her

Heather Church

Heather studied Biology and Chemistry at Goldsmith’s College, University of London, graduating in 1987. She then gained a Ph.D. in analytical chemistry from the Department of Chemistry, University of Manchester in 1991. Heather worked as a post-doctoral research scientist within the Department of Obstetrics and Gynaecology, University of Manchester from 1991-1999 with a specific interest in cell adhesion and the role of extracellular matrix in human physiology.

In 1999 Heather took up the position of Clinical Biochemist in the Willink Biochemical Genetics Unit, now part of the Genomic Medicine, Manchester Foundation Trust with a specialist interest in lysosomal disease. Heather was appointed Principal Clinical Scientist in 2008 and has overseen the introduction of highly specialised laboratory services focussing on the improved diagnosis and monitoring treatment efficacy of pioneering new treatments for patients with lysosomal disease.

David Dorwood

No bio provided

Allan Dunlop

I am a Consultant Clinical Scientist within the Department of Clinical Biochemistry, Queen Elizabeth University Hospital (NHS Greater Glasgow & Clyde).

I began my Clinical Scientist training at Aberdeen Royal Infirmary (NHS Grampian) in 2010, moving to Glasgow in 2013. My current areas of interest include Core Biochemistry and automation, Toxicology and therapeutic drug monitoring.

Pronouns: He/him/his

Fadoua El Hiayadi

Fadoua El Hiayadi is a Specialist Biomedical Scientist with extensive experience in multidisciplinary laboratory sciences, including transfusion, haematology, coagulation, and immunology. She has worked in renowned institutions such as Carlos Haya Hospital in Malaga, Spain (2012-2013), and South Hants Hospital (2015-2016), where she worked as a phlebotomist. Currently, she contributes her expertise as a team leader at Southampton General Hospital, focusing on performing advanced laboratory diagnostics and providing clinical support.

With a strong academic foundation and years of hands-on experience, Fadoua is committed to advancing healthcare through innovation and excellence in diagnostics.

Danielle Freedman

Consultant Chemical Pathologist, Associate Physician in Endocrinology, Clinical Director of Pathology, and Deputy Medical Director of Bedfordshire Hospitals (cross site).  Lead CMO for ME5 Pathology Network.

Trained in medicine at the Royal Free Hospital School of Medicine, University of London, and then further training in Clinical Biochemistry and Endocrinology at the RFHSM and the Middlesex Hospital, University of London.

Nationally, elected Vice President of Royal College of Pathologists (RCPath) (2008 - 2011)  

National member of the Association for Clinical Biochemistry and Laboratory Medicine (ACB) Council 2011 - 2015.  Currently, UK member of the (EFLM) Working Group on Post Analytic Phases (2018 - 2023)

 Chair of Lab Tests Online Board UK (2012 - ) A Peer reviewed, Non Commercial, Patient Centered website

Main interests include clinical endocrinology, point of care testing and, importantly, the value of laboratory testing with regard to patient safety and patient outcome.

 Over 100 publications in peer review journals including Lancet, New England Journal of Medicine, JAMA and Annals of Clinical Biochemistry and 10 book chapters.

Nominated as one of the TOP 100 International Power List of Influential Laboratory Medicine Professionals (November 2015)

In 2018, awarded the very prestigious award of Honorary Membership of the ACB for her International work in Laboratory Medicine.

Pronouns:  She/her/hers

Naomi Gadsby

Naomi Gadsby has a PhD from the University of Edinburgh and completed her pre- and post-registration clinical scientist training in Medical Microbiology in NHS Lothian. She became a Fellow of the Royal College of Pathologists by examination in Medical Microbiology in 2017. Since 2019 she has been working as a Consultant Clinical Scientist in Medical Microbiology at the Royal Infirmary of Edinburgh.

Ian Godber

Ian trained in Clinical Biochemistry in Dundee and Nottingham, then moved to NHS Lanarkshire initially as a Principal Biochemist, and was later appointed to a post as Consultant Clinical Scientist and Clinical Lead, where he developed an interest in laboratory processes and IT. He was the Clinical Lead for the Scottish Clinical Biochemistry Managed Diagnostic Network from 2016-2020. He moved into his current role as Consultant Clinical Scientist and Lead Clinician in Biochemistry at the QEUH in Glasgow in 2020.

Ian currently chairs the Specialist Advisory Committee for Clinical Biochemistry within the Royal College of Pathologists and after sitting on many committees of the Association for Laboratory Medicine, he was appointed as President Elect in 2024 and will take up the Presidency at LabMedUk in Manchester later this year.

Pronouns:  He/him/his

Nicole Gossan

I am a Principal Clinical Scientist in Genomics, working in rare disease at the Manchester Genomic Laboratory Hub (NWGLH). I am the lead for the Metabolic genetics service within the lab. I have previously worked in NHS Genomics laboratories in Nottingham and Liverpool.

Prounouns:  Dr/she/her

Dominic Haigh

Dominic is a medical doctor who trained in Clinical Virology and Infectious Diseases in Manchester.  He works Manchester Medical Microbiology Partnership for the NHS and the UK Health Security Agency. He teaches and examines for the University of Manchester. Dominic enjoys interesting cases and education, and has been involved in research, audit and Quality Improvement work regarding Covid, mpox, High-Consequence Infectious Diseases and other infections.

Pronouns: He/ him

Sally Hanton

Sally is a Principal Clinical Scientist in Neurobiochemistry and Neuroimmunology, working in the Neuroscience Laboratories at The Walton Centre NHS Foundation Trust in Liverpool. On completion of her BSc in Biochemistry, Sally undertook a PhD and several years of postdoctoral work researching intracellular protein transport. She then went on to train as a clinical scientist in Liverpool, and has worked in her current role since 2016.

Sally’s interests include therapeutic drug monitoring and measurement of neurologically relevant metabolites using UPLC-MS/MS, as well as the development of methods to detect potential novel autoantibodies.

Melanie Hart

Dr Melanie Hart is a Consultant Clinical Scientist and Laboratory Director of the Neuroimmunology and CSF Laboratory (NICL) at the National Hospital for Neurology in London (UCLH) with a honorary research contract with University College London and a Fellow of the Royal College of Pathologists. As Laboratory Director she oversees a comprehensive repertoire of diagnostic NHS neurological tests the specialist centre provides to hospitals across the UK from dementia markers to autoimmune neurology tests. She is supported by the NIHR UCL Biomedical Research Centre and is a collaborator on current grants including the Blood Biomarker Challenge for Alzheimer’s Disease (ADAPT) Trial and Translation Accelerator Grant for diagnostic alpha synuclein biofluid measurement in Parkinson’s disease, working to translate these tests into clinical use in NICL. She is a committee member of the Specialist Advisory Group for Neuroimmunology at UK NEQAS and a member of the Association for British Neurologists, British Society for Immunology and Association of Laboratory Medicine.

Katharine Hayden

Kath Hayden is a Consultant Clinical Biochemist at Manchester University NHS Foundation Trust and Honorary Senior Lecturer at the University of Manchester.

Following training in South Manchester, Kath has held posts in hospitals in Manchester and Liverpool over a 35 year period, overseeing significant advances in analytical technologies, point of care testing (POCT) and harmonisation of laboratories. With specialist interests in endocrinology, POCT, leadership and service improvement, her latest roles have been as Clinical Head of Division for Laboratory Medicine at Manchester University NHS Foundation Trust, Trust Lead Healthcare Scientist, Clinical Director for Laboratory Medicine and Head of Service for Clinical Biochemistry at Central Manchester University Hospitals NHS Foundation Trust.  

Nuthar Jassam

Nuthar is a Consultant Clinical Biochemist and Head of Biochemistry Department at Harrogate and District NHS Foundation Trust and a Clinical Director of Blood Sciences  Departments for a network of three laboratories; Harrogate, Airedale and Bradford.

Nuthar takes pride in the fact that she enjoys research in any area of Clinical Biochemistry. She published over 45 papers and article reviews and over 22 abstract and conference papers. She is known for her interest in harmonisation of postgraduate training across Europe and standardisation of pathology practices within clinical networks. She brings experience in the field of quality of laboratory medicine by being member of a number of Experts on Laboratory Quality working groups and an invited speaker on national and international platforms in this field.

Nuthar has been a member/chair of a number of working groups and committees within the Association of Clinical Biochemistry and Laboratory Medicine in the UK. She currently chairs the European Federation of Laboratory Medicine (EFLM) Register. Nuthar previously chaired the EFLM working group for the post- graduate syllabus for European laboratory medicine specialists and was a board member of the European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4).

Pronouns:  She/her

Helen Jopling

Helen completed her Biochemistry degree and PhD at the University of Leeds with a year spent studying in Paris. Her clinically focussed PhD led to training as a clinical scientist at Manchester Royal Infirmary, before taking up a substantive post at Royal Manchester Children’s Hospital. Helen started guest lecturing on the MSc programme provided at the University of Manchester to accompany STP training, and this led to taking on a permanent contract. Helen is Director of Education in the school of medical sciences, leading the provision of degree programmes at both undergraduate and postgraduate level. Alongside this Helen maintains a teaching and research portfolio in Clinical Biochemistry and Medical Education, and has a role as an associate editor for the Annals of Clinical Biochemistry.

Tejas Kelaria

Dr Tejas Kalaria is a Consultant in Chemical Pathology and Metabolic Medicine at Black Country Pathology Services, The Royal Wolverhampton NHS Trust, and Member Young Scientist on the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) post-analytical phase working group. Dr Kalaria’s areas of interest include endocrine biochemistry and post-analytics.

Pronouns:  He/him/his

Thomas Lamb

Thomas Lamb is an infectious diseases consultant working at North Manchester General Hospital. Thomas has taken time out of his medical training to work in India, Bangladesh and Myanmar. During this time he has developed an interest in Toxicology and snakebite. Following his return to the UK, he has completed registrar training in Infection medicine before obtain a CCT in Medical microbiology and infectious diseases in 2024.

Phillip Monaghan

After graduating from the University of Manchester Institute of Science and Technology (UMIST) in Biochemistry with Applied Molecular Biology, Phillip went on to complete a PhD in Molecular Enzymology at the University of Leicester.  He subsequently commenced training in Clinical Biochemistry at Wirral University Teaching Hospital, Alder Hey Hospital and University Hospital of South Manchester.  Phillip has been a Clinical Scientist at The Christie NHS Foundation Trust and more recently The Christie Pathology Partnership in Manchester, UK, for the past 15 years, and is Clincal Director of Pathology.  Phillip is Honorary Lecturer at the University of Manchester, Cancer Sciences Division within the School of Medical Sciences, previously lecturing on the MSc Clinical Sciences programme and the Advanced Therapeutics Medicinal Products programme.  Phillip is a member of the UK NEQAS Steering Committee for Immunochemistry, and previous Chair of the NQAAP for Chemical Pathology (Chair: 2019-2022).  Phillip is Chair of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Test Evaluation (WG-TE) and is Editor-in-Chief for the Annals of Clinical Biochemistry. 

Special research interests include evidence-based laboratory medicine (test evaluation), biochemical endocrinology, and translational biomarker development. Phillip is Co-Investigator on the VALTIVE clinical trials programme for the validation of a novel vascular response biomarker to guide VEGFi therapy in ovarian cancer.  Phillip was awarded the Silver Research Medal from the Royal College of Pathologists in 2012 for his work on serum cortisol measurement in Cushing’s syndrome. 

Elaine Murphy

No bio provided

Karen Perkins

A diverse career to date, which includes post-doctoral research associate at National Heart and Lung Institute, London, team leader at Unilever R&D working on a project focused on what it takes to be a healthy octogenarian – living healthy for longer. I am currently Principal Clinical Scientist at Morecambe Bay Hospitals NHS Trust, since 2020. I have a special interest in capillary sampling and enabling access to blood tests for underserved populations.

Pronouns:  She/her

Kate Phillips

Catherine (Kate) is a Clinical Scientist and is on the Higher Specialist Scientist Training programme in Clinical Virology. She currently works with the Manchester Microbiology Partnership for both NHS and UKHSA. She has previously worked in Microbiology as a Senior Biomedical Scientist. Catherine has interest in Hepatitis C, DNA viruses, and the application of next-generation sequencing and bioinformatics in viral research.

Pronouns:  She/her

Monika Radike

Dr Monika Radike MD, PhD, FRCR is a Consultant Cardiothoracic Radiologist practicing at Liverpool Heart and Chest Hospital NHS Foundation Trust, UK. While working as a clinical radiologist, she has also been involved in various research projects, presentations and publications in her field. Dr Radike actively participates in medical education, training and mentoring radiologists, and has established a radiology fellowship programme at Liverpool Heart and Chest Hospital. 

Tricia Ravalico

Tricia Ravalico is founder and executive lead of the UNIVANTS of Healthcare Excellence Program, a prestigious global award program that was developed to recognize, amplify and inspire best practices in healthcare transformation.  She also leads Global Scientific Leadership at Abbott with responsibilities that include cultivation of scientific partnerships, collaborations, and the development of global education strategies across congresses and healthcare disciplines. 

Tricia serves on the Executive Board of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), is also a liaison to the IFCC Task Force for Corporate Members where she has also served as chair for 4 years.  She was formerly a board member of the IFCC Publications and Communications Division for 6 years, and has actively supported multiple IFCC programs for over a decade including the IFCC Committee for the Clinical Application of Cardiac Bio-Markers (CCB).

Over the course of her 28-year career in core diagnostics, she has held multiple leadership positions in Research and Development, Scientific Affairs, Medical Affairs, Global Marketing and Education.

Riina Richardson

Dr Richardson is the Clinical Head of Service for the Mycology Reference Centre Manchester and member of the MFT Infectious Diseases team. She is an internationally recognised expert, senior researcher, educator and clinician.  She has published over 180 peer-reviewed articles and book chapters in medical microbiology, mucosal immunology and infectious diseases, h-index is 51.

She has special expertise in the management of a spectrum of mycoses including chronic superficial candidiasis, candidaemia and other fungal infections in immunocompromised, as well as in antimicrobial stewardship and infection prevention. She is an author of the BASHH guideline on vulvovaginal candidiasis as well as the ECMM/ISHAM Candidiasis and Rare yeasts guidelines. She is the Lead for Infectious Diseases learning for University of Manchester Medical School, the Chair of the UK SMI Bacteriology Working Group, an ESCMID Educational Officer and lead for the eAcademy, and an Editor for Journal for Antimicrobial Chemotherapy.

Pronouns:  She/her

Fiona Riddoch

Fiona trained as a Clinical Scientist in Biochemistry. Currently employed as a Consultant Clinical Scientist for POCT in Berkshire and Surrey Pathology Services (BSPS); the service covers 5 acute NHS Trusts, and multiple community services. Over the last 5 years she has developed multidisciplinary clinical and technical expertise needed for POCT, and in particular focussing on IT, risk management and analytical & clinical verification of POCT analysers, using these skills to support the BSPS POCT team in achieving accreditation against ISO:15189(2022) for our multi-site blood gas analyser service. She has led the BSPS POCT team on national verification projects, including multiple SARS-CoV-2 and winter multiplex methods on behalf of NHS England, being an exemplary verification and implementation site for POCT in Hospital@Home services; working to provide evidence that can be used nationally to support implementation of POCT CRP and high-sensitivity troponin. She has won national awards for quality improvement projects and clinical audit, by demonstrating clinical impact and patient benefit of pathology services.

Emma Stevenson

Emma is a principal clinical scientist based in the clinical biochemistry laboratories at Gloucestershire Hospitals NHS Foundation Trust. She is Chair of the LabMed Education Group and Deputy Director of Education, Training and Workforce. Outside of education and training, Emma’s main interest in the laboratory is quality, including EQA, IQC and measurement uncertainty. Emma is a member of the RCPath’s Chemical Pathology National Quality Assurance Panel, which oversees the running of EQA schemes in biochemistry.

Pronouns:  She/her

Nathan Timbrell

Nathan is a Senior Biomedical Scientist working within Synnovis, St Thomas' Hospital in London. He began his career on the Practitioner Training Programme (PTP) and trained at Royal Devon and Exeter Hospital. He later worked within Clinical Biochemistry at both Royal United Hospitals Bath and North Bristol NHS Trust, gaining experience in specialist sections such as Newborn Screening, Biochemical Genetics, and Clinical Toxicology. This gave Nathan exposure to several different chromatography and mass spectrometry methods. Now, he utilises this expertise within the Human Nutristasis Unit, a laboratory that specialises in the static and functional markers of vitamin status, along with testing related to warfarins and superwarfarins.

Nathan is currently undertaking equivalence training to register as a Clinical Scientist. As part of this, he has recently completed both an MSc in Biomedical Science and passed the IBMS Higher Specialist Diploma in Clinical Chemistry. These qualifications led Nathan to join the IBMS Specialist Advisory Panel in Clinical Biochemistry, where he is able to advise on science and policy. Nathan's interests also led him to become the deputy manager of the KEQAS external quality assurance scheme for  Protein induced by vitamin K absence-II (PIVKA-II).

Pronouns: He/him/his

Philip Turner

Dr Phil Turner is a senior researcher in the Infections, Respiratory and Acute care Research Group and the Director of Operations of the NIHR HealthTech Research Centre in Community Healthcare based at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. His research interests include the diagnosis and management of common infections and approaches to antimicrobial stewardship in community healthcare settings. Recent activities include co-leadership of the RAPTOR-C19 evaluations of point-of-care tests for SARS-CoV-2 and other respiratory viruses in community care, trial management support for the trans-European VALUE-Dx PRUDENCE RCT of the clinical and cost-effectiveness of diagnostic interventions for RTI, and co-investigation on the NIHR and NHSE-funded TOUCAN evaluation of novel diagnostics for acute uncomplicated UTI.

Pronouns:  He/him/his

Ed Wilkes

Ed completed his PhD and post-doctoral work at Barts Cancer Institute, where he developed computational methods for predicting drug response to small kinase inhibitors in cancer models. He went on to train as a clinical scientist in the NHS and is now the Head of Research at Kinomica. His interests primarily lie in predictive modelling, statistics education, systems biology, and (phospho-)proteomics.

Pronouns: He/him/his

Alexandra Yates

Mrs. Alexandra Yates (She/Her). Director of Scientific Affairs-The Association for  Laboratory Medicine.

Alexandra, is a  Consultant Clinical scientist in the Clinical biochemistry department at the Countess of Chester hospital, GB, where her interest include analytical interferences, renal medicine, and quality improvement. Other wider interest include equality and diversity within  healthcare organizations, Alexandra is passionate in  enacting meaningful change leading to equity for all and recognizing the benefits this bring  to the healthcare and wider community.

Alexandra was appointed as Director of Scientific affairs for the Association for clinical biochemistry and Laboratory medicine in May 2019 after 5 years on the scientific committee, and a previous role   as a national member on the ACB council.

As chair of the Scientific and clinical practice committee, she leads  the committee in the vision  that; the scientific committee  and clinical practice committee should serve all LabMed members across pan-pathology disciplines,  enabling and promoting  translation  research and innovation,  and providing  scientific and clinical expertise to  our strategic partners, benefiting the  wider health care  community.

Pronouns:  She/her